Clinical trial
Intravenous Immunoglobulin After Relapse in Vasculitis
NCT00307658 · Assistance Publique - Hôpitaux de Paris, Other · Terminated
Key facts
| NCT number | NCT00307658 |
|---|---|
| Title | Intravenous Immunoglobulin After Relapse in Vasculitis |
| Official title | Intravenous Immunoglobulin After Relapse in Vasculitis (Microscopic Polyangiitis, Wegener's Granulomatosis and SHURG-STRAUSS Syndrome) During and After Corticosteroids and Immunosuppressant Therapies a Multicenter Prospective Trial |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | ANCA + Vasculitides Relapsing Either Under Corticosteroid, and Immunosuppressant Therapies or After One Year, Post Treatment. |
| Intervention type | Drug |
| Interventions | Intravenous immunoglobulins (human immunoglobulins G) |
| Enrollment | 40 |
| Start date | Mar 1, 2001 |
| Completion | Jul 1, 2006 |
| First posted | Mar 28, 2006 |
| Last update posted | May 22, 2006 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: